share_log

Healthcare Triangle, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Healthcare Triangle, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Healthcare Triangle, Inc. 公布2023年第四季度和全年财务业绩
GlobeNewswire ·  03/15 09:28

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("Healthcare Triangle," "HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, data analytics and AI data processing for the healthcare and life sciences industries, today announced financial results for its fourth quarter and full year ended December 31, 2023.

加利福尼亚州普莱森顿,2024年3月15日(GLOBE NEWSWIRE)——医疗保健和生命科学行业数字化转型解决方案的领导者,包括医疗保健和生命科学行业的托管服务、云支持、网络安全、数据分析和人工智能数据处理,三角医疗保健公司(纳斯达克股票代码:HCTI)(“医疗三角” 或 “公司”)今天公布了截至2023年12月31日的第四季度和全年财务业绩。

Fourth Quarter 2023 Financial Results

2023 年第四季度财务业绩

  • Revenue: Total revenue was $7.1 million, representing a decrease of 37% compared to the fourth quarter of 2022. Revenue from the Software Services and Managed Services segments decreased by 40% and 37%, respectively, partially offset by a 22% increase in Platform Services.
  • GAAP loss from operations: GAAP loss from operations was $5.3 million, compared to $4.9 million in the fourth quarter of 2022. The increased loss was primarily due to impairment of intangibles and goodwill. The one-time impact of the impairment was $4.2 million. The normalized GAAP loss from operations was $0.7 million.
  • GAAP net loss per share: GAAP basic and diluted net loss per share was $1.26 based on 4.2 million weighted-average shares outstanding, compared to $1.33 based on 3.6 million weighted-average shares outstanding in the year-ago quarter.
  • 收入:总收入为710万美元,与2022年第四季度相比下降了37%。软件服务和托管服务板块的收入分别下降了40%和37%,部分被平台服务22%的增长所抵消。
  • GAAP运营亏损:GAAP运营亏损为530万美元,而2022年第四季度为490万美元。亏损增加的主要原因是无形资产和商誉减值。减值的一次性影响为420万美元。正常的GAAP运营亏损为70万美元。
  • GAAP每股净亏损:根据420万股已发行加权平均股票,GAAP基本净亏损和摊薄后每股净亏损为1.26美元,而去年同期已发行的360万股加权平均股为1.33美元。

Full Year 2023 Financial Results

2023 年全年财务业绩

  • Revenue: Total revenue was $33.2 million, representing a decrease of 28% compared to 2022. Revenue from Software Services, Managed Services and Support and Platform Services revenue has decreased in the current year.
  • GAAP loss from operations: GAAP loss from operations was $12.3 million, compared to $9.6 million in 2022. The increased loss was primarily due to impairment of intangibles and goodwill. The onetime impact of the impairment was $4.2 million. The normalized GAAP loss from operations was $8.1 million.
  • GAAP net loss per share: GAAP basic and diluted net loss per share was $2.92 based on 4.2 million weighted-average shares outstanding, compared to $2.63 based on 3.6 million weighted-average shares outstanding in 2022.
  • Cash and cash equivalents totaled $1.2 million as of December 31, 2023.
  • 收入:总收入为3,320万美元,与2022年相比下降了28%。本年度,软件服务、托管服务和支持以及平台服务收入的收入有所下降。
  • GAAP运营亏损:GAAP运营亏损为1,230万美元,而2022年为960万美元。亏损增加的主要原因是无形资产和商誉减值。减值造成的一次性影响为420万美元。正常的GAAP运营亏损为810万美元。
  • GAAP每股净亏损:根据420万股加权平均已发行股票,GAAP基本净亏损和摊薄后每股净亏损为292美元,而根据2022年已发行的360万股加权平均股票,GAAP基本净亏损和摊薄后的每股净亏损为2.63美元。
  • 截至2023年12月31日,现金及现金等价物总额为120万美元。

Business Highlights:

业务亮点:

  • Secured a new $3 million contract to provide HITRUST-certified Cloud DevOps Managed Services for a leading life sciences customer, reinforcing the Company's position as a top player in the Cloud DevOps Managed Services business.
  • Secured a multi-year program expansion contract with a Fortune 500 biopharmaceutical company, securing our position as one of the providers for Cloud DevOps, data engineering and data platform management solutions.
  • Announced a multi-year subscription agreement with a long-standing customer for readabl.ai, a medical document automation solution aimed at streamlining patient care and reducing operating costs.
  • Launched a new ransomware protection and prevention initiative drawing initial interest and support from numerous health system clients. The Company is servicing multiple contract agreements for cloud backup and disaster recovery, allowing hospitals and health systems to move disaster recovery to the Amazon Web Services (AWS) cloud to secure resources and scale on demand.
  • Hosted sessions on digital transformation and ransomware preparedness for healthcare systems at CHIME23 fall forum.
  • Hosted roundtable discussion on generative AI and data modernization strategies for healthcare and hosted webinar addressing ransomware preparedness for healthcare.
  • Participated in 2023 MUSE Inspire conference as exhibitor and host of best practice sessions and at HIMSS23 conference as a guest speaker for Amazon Web Services.
  • 获得了一份价值300万美元的新合同,为一家领先的生命科学客户提供经Hitrust认证的云开发运营管理服务,巩固了公司作为云开发运营托管服务业务领先者的地位。
  • 与一家财富500强生物制药公司签订了为期多年的项目扩展合同,确保了我们作为云开发运营、数据工程和数据平台管理解决方案提供商之一的地位。
  • 宣布与一位长期客户 readabl.ai 签订多年期订阅协议,这是一种医疗文档自动化解决方案,旨在简化患者护理和降低运营成本。
  • 启动了一项新的勒索软件保护和预防计划,获得了众多卫生系统客户的初步兴趣和支持。该公司正在为多份云备份和灾难恢复合同协议提供服务,允许医院和医疗系统将灾难恢复转移到亚马逊网络服务 (AWS) 云,以保护资源并按需扩展。
  • 在 CHIME23 秋季论坛上主持了关于医疗保健系统的数字化转型和勒索软件防范的会议。
  • 主持了关于医疗保健行业生成式人工智能和数据现代化策略的圆桌讨论,并主持了有关医疗保健领域勒索软件防范工作的网络研讨会。
  • 作为参展商和最佳实践会议主持人参加了 2023 年 MUSE Inspire 会议,并作为亚马逊网络服务的演讲嘉宾参加了 HIMSS23 会议。

Thyagarajan Ramachandran, Chief Financial Officer of Healthcare Triangle, stated, "Despite experiencing a decline in revenue throughout the year, we achieved significant milestones by launching some key initiatives in ransomware protection and preparedness for our clients. During the year we secured notable multi-year contracts. We believe the steps we have taken will make us a top provider of cybersecurity solutions as well as a leading provider in AI-driven healthcare process and workflow in the future. Because of the work we completed during full year 2023, we have already seen the fruits of our labor lead to many new initiatives in 2024. The Company is in multiple discussions with healthcare companies looking at our AI solutions to bring their existing systems up to date and creating new standards while providing potential cost savings and productivity gains. The healthcare landscape is continually evolving, generating a significant amount of data on a daily basis, driven by patient care, payment systems, regulatory compliance and recordkeeping. HCTI continues to be a leader in innovation as we make improvements to our HITRUST-certified Cloud DevOps managed services and AI adoption. AI in the healthcare market is projected to reach $53 billion by 2024, according to Grand View Research, and this presents many opportunities for documentation AI and generative AI for us and our solutions. A key strategy for both customer acquisition as well as marketing and brand visibility has been educating potential customers and the industry at large by hosting webinars and participating in conferences and guest speaking. We believe we are positioned ideally and have made major strides in 2023."

Healthcarajan Ramachandran首席财务官Thyagarajan Ramachandran表示:“尽管全年收入有所下降,但我们在勒索软件保护和为客户做好准备方面启动了一些关键举措,取得了重要的里程碑。在这一年中,我们获得了值得注意的多年期合同。我们相信,我们所采取的措施将使我们成为网络安全解决方案的顶级提供商,以及未来人工智能驱动的医疗保健流程和工作流程的领先提供商。由于我们在2023年全年完成的工作,我们已经看到我们的劳动成果在2024年带来了许多新举措。该公司正在与医疗保健公司进行多次讨论,研究我们的人工智能解决方案,以使其现有系统保持最新状态并创建新标准,同时提供潜在的成本节省和生产率的提高。医疗保健格局在不断变化,在患者护理、支付系统、监管合规和记录保存的推动下,每天都会生成大量数据。随着我们对经Hitrust认证的Cloud DevOps托管服务和人工智能采用进行改进,HCTI仍然是创新领域的领导者。根据Grand View Research的数据,到2024年,医疗保健市场的人工智能预计将达到530亿美元,这为我们和我们的解决方案提供了许多记录人工智能和生成人工智能的机会。获取客户以及营销和品牌知名度的关键策略是通过举办网络研讨会、参加会议和嘉宾演讲来教育潜在客户和整个行业。我们相信我们的定位理想,并在2023年取得了长足的进步。”

About Healthcare Triangle:

关于医疗保健三角:

Healthcare Triangle, Inc., headquartered in Pleasanton, California, stands at the forefront of healthcare technology, specializing in AI and digital transformation. With a commitment to innovation, collaboration, and excellence, Healthcare Triangle is dedicated to reshaping healthcare delivery for the better. We collaborate with healthcare entities, including hospitals, health systems, payers, and pharma/life sciences organizations, leveraging breakthrough technology and extensive industry expertise to enhance health outcomes through optimized data utilization and cutting-edge information technologies. Holding HITRUST Certification for Cloud and Data Platform (CaDP) – featuring CloudEz, DataEz, and readabl.ai – our commitment to the highest standards in data protection and information security is unwavering. Healthcare Triangle serves as a beacon for the adoption of new technologies, data enlightenment, business agility, and swift response to evolving business needs and competitive challenges. Thriving in the highly regulated healthcare and life sciences sectors, we excel in digital transformation encompassing the cloud, security and compliance, identity management, data lifecycle management, healthcare interoperability, and clinical and business performance optimization. For more information, visit .

总部位于加利福尼亚州普莱森顿的Healthcare Triangle, Inc. 站在医疗保健技术的最前沿,专门从事人工智能和数字化转型。Healthcare Triangle 致力于创新、协作和卓越,致力于重塑医疗保健服务,使其变得更好。我们与医疗保健实体合作,包括医院、卫生系统、支付方和制药/生命科学组织,利用突破性技术和广泛的行业专业知识,通过优化数据利用和尖端信息技术来改善健康成果。持有 HITRUST 云和数据平台 (CadP) 认证 — 以 CloudeZ 为特色,DataEZ,以及 readabl.ai — 我们对数据保护和信息安全的最高标准的承诺坚定不移。Healthcare Triangle 是采用新技术、数据启发、业务敏捷性以及快速应对不断变化的业务需求和竞争挑战的灯塔。我们在高度监管的医疗保健和生命科学领域蓬勃发展,在数字化转型方面表现出色,包括云、安全与合规、身份管理、数据生命周期管理、医疗互操作性以及临床和业务绩效优化。欲了解更多信息,请访问。

Forward-Looking Statements and Safe Harbor Notice

前瞻性陈述和安全港通知

All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on March 28, 2023, subsequent filings and future reports filed with the SEC. All the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

本新闻稿中除历史事实陈述以外的所有陈述均为 “前瞻性陈述”(定义见1995年《私人证券诉讼改革法》)。此类前瞻性陈述包括我们的预期以及那些使用前瞻性词语的陈述,例如 “预期”、“预期”、“可能性” 和 “预期”。此类前瞻性陈述所涵盖事项的成就或成功涉及重大风险、不确定性和假设。实际结果可能与当前的预测或隐含的结果存在重大差异。投资者应阅读公司于2023年3月28日向美国证券交易委员会提交的10-K表年度报告、随后向美国证券交易委员会提交的文件和未来报告中列出的风险因素。公司的所有前瞻性陈述均受所有此类风险因素和其他警示性陈述的明确限制。

The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time the statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.

公司警告说,本新闻稿中的陈述和假设构成前瞻性陈述,不能保证未来的表现。前瞻性陈述基于发表声明时管理层的估计和意见。此处提供的信息仅代表截至本文发布之日。在本新闻发布之日之后,公司及其管理层没有义务修改这些声明。

Contacts

联系人

Investors:
1-800-617-9550
ir@healthcaretriangle.com

投资者:
1-800-617-9550
ir@healthcaretriangle.com


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发